Paracetamol (Acetaminophen) Poisoning Evidence Based Review

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Paracetamol (Acetaminophen) Poisoning Evidence Based Review"

Transcription

1 Paracetamol (Acetaminophen) Poisoning Evidence Based Review Context Deliberate self harm is a common reason for presentation to the ED, with paracetamol poisoning being one of the most common methods used in the UK. Paracetamol poisoning accounts for over 40% of poisoning admissions and deaths per annum. Legislation introduced in September 1998 has reduced pack sizes of paracetamol and aspirin to 16 (32 from a pharmacy). There is some evidence of a reduction in serious overdoses since this change. Death may result from hepatic necrosis, renal and respiratory failure, major haemorrhage and coma. These conditions take between two and three days to develop. Renal failure may occur in the absence of liver impairment. Pathophysiology Paracetamol is rapidly absorbed, with an absorption half-time of only 30 minutes (just five minutes for paediatric elixir), and enters cells by passive diffusion. It is metabolised down three pathways. The predominant pathway is glucuronadation, with sulphation playing a smaller role. The products of these pathways are harmlessly excreted in the urine, along with 5% of the ingested paracetamol. In children, sulphation plays a greater part in paracetamol metabolism than it does in adults. This means that children are less prone to toxicity, but there is insufficient research to prove how much of a difference there truly is. The metabolic pathway causing the problems in overdose is where cytochrome p450 subtype 2E1 (CYP2E1) metabolises paracetamol to N-acetyl-p-benzoquinone imine (NAPQI) in the liver. This extremely reactive compound is produced from approximately 5% of ingested paracetamol and is usually disposed of harmlessly by reaction with glutathione to form mercapturic acid, which is subsequently excreted in the urine. With a large enough paracetamol overdose, the glutathione donor groups stored in the liver are depleted to such a level that the NAPQI starts to bond with and destroy vital cellular structures. Lipids are peroxidated, proteins change conformation and mitochondria are unable to produce ATP effectively. Instead, hydrogen peroxide and oxygen free radicals are formed. Kupffer macrophages are activated by cytokines, which are released by the damaged hepatocytes. In turn, the Kupffer macrophages release various interleukins (IL-1, 6, 8 and 10) and TNFα. IL-6 triggers apoptosis of the hepatocytes while IL-10, on the other hand, stimulates hepatocyte regeneration (if enough survive). The resultant hepatic necrosis and failure leads to jaundice and hepatic coma, failure of production of clotting factors leading to bleeding, and vast quantities of inflammatory mediators that cause a systemic inflammatory response to evolve.

2 High risk groups These can be divided into two groups: Glutathione depletion Chronic excess alcohol HIV/AIDS Malnutrition e.g. anorexia nervosa Cystic fibrosis Cytochrome enzyme induction Chronic excess alcohol Anticonvulsants St. John s Wort Rifampicin It is accepted for the purposes of generalisation and simplicity that these patients can only tolerate approximately half the dose of paracetamol in excess that a low risk patient can. Toxic ingestion In the event of overdose, the likelihood of serious hepatic injury can be estimated by knowing the amount taken and the weight of the patient. Ingested dose Likelihood of serious toxicity <150 mg/kg Unlikely >250 mg/kg Likely (potentially fatal) Therefore, for a 70 kg man, 150 mg x 70 kg = 10.5 g = 21 tablets constitute a significant overdose. In the UK, the standard dose for paracetamol tablets is 500 mg, but it is important to be aware that some compound preparations may contain different amounts, e.g. 325 mg in coproxamol. Tylenol 8 hour and Tylenol Arthritis, both from the USA, contain a rapid release 325 mg dose and a slow release 325 mg dose in the same tablet. Many patients present having taken their overdose with alcohol or in a distressed state, so it may be difficult to get an accurate history of the amount ingested. In these cases one should consider erring on the side of caution and assume a higher dose than stated. Presentation < 24 hours - may be asymptomatic or have nausea, vomiting +/- abdominal pain - abdomen is often tender in epigastrium or right upper quadrant > 24 hours - may have mild jaundice > 48 hours - deep jaundice - bleeding - encephalopathy

3 Antidotes There are two commonly used antidote treatments, both of which work by being precursors to glutathione and replenish hepatic stores. Glutathione binds to the toxic metabolite, NAPQI, to form inactive mercapturic acid, which is excreted renally. This prevents NAPQI from binding to other, more important, molecules. N-acetyl cysteine has the advantage of being a free-radical scavenger, independent of the above. In the UK, the standard treatment is N-acetyl cysteine given intravenously. The infusion regime involves three fluid bags. The first is a loading dose with 150 mg/kg in 200 ml of 5% dextrose over 15 minutes, followed by 50 mg/kg in 500 ml over four hours, and then finally 100 mg/kg diluted to 1 l over 16 hours. The volumes of diluent are reduced in children to avoid fluid overload. N-acetyl cysteine is generally well tolerated, but 5% of patients receiving it will suffer an anaphylactoid reaction with flushing, itching, wheeze and vomiting. The patient may already be vomiting from the paracetamol. The patient usually responds well to slowing or stopping the infusion temporarily and administration of an antihistamine. It normally only occurs during the loading dose bag. Anaphylactoid reactions are not a contra-indication to further treatment with N-acetyl cysteine, but patients who attend frequently with overdoses may refuse it as it makes them feel unwell. In the USA, N-acetyl cysteine is administered orally in similar doses. The second-line treatment in the UK is methionine. This has the disadvantage of being an oral drug in a situation where the patient is often vomiting due to the toxic effects of the paracetamol. Its efficacy has not been studied in the same depth as N-acetyl cysteine. A course for an adult consists of four doses of 2.5 g at four-hourly intervals. Methionine is incorporated in some paracetamol preparations by law in some countries to prevent fatal overdose. It is available in the UK over the counter in this combination, but is not popular as it remains expensive and causes nausea and vomiting. Timing of ingestion changes management The first priority with any poisoned patient is the ABC approach. Paracetamol is present in many codeine-containing compound analgesics, where the codeine may cause significant respiratory and central nervous system depression. These patients may need airway manoeuvres +/- naloxone. Other co-ingestants, such as antidepressants, may require more urgent management for similar reasons. The following management algorithms for the ED assume that these factors have been addressed. If in doubt, contact your local poisons information service. < 4 hours in adults consider 50 g oral activated charcoal if: - patient presents within one hour of ingestion and - they have taken >150 mg/kg or 12 g in total wait until four hours post-ingestion to take blood for a paracetamol level

4 treat patient with IV N-acetyl cysteine if level >1.3 mmol/l if low risk or >0.65 mmol/l if high risk < 4 hours in children consider oral activated charcoal if: - patient presents within one hour of ingestion and - they have taken >150 mg/kg or 12 g in total dose of charcoal is 1 mg/kg in infants or g in children under 12 years if it is certain that the child has taken less than 150 mg/kg, they may safely be discharged and the parents reassured if there is doubt, or the child has definitely taken >150 mg/kg, they should be investigated and treated as for adults above By measuring the amount remaining in a bottle that a child has drunk from, it is possible to calculate the maximum possible dose taken. Paracetamol elixir comes in two concentrations: 120 mg/ 5 ml and 250 mg/ 5 ml. The largest bottle sizes of Calpol are 200 ml of low strength mixture and 100 ml of high strength mixture. Therefore, the maximum any bottle can contain is 250/5 x 100 = 5 g. Hence, a child over approximately 35 kg can drink an entire bottle without reaching the 150 mg/kg threshold. 4-8 hours (all patients) measure paracetamol level immediately if result will be available before eight hours post-ingestion, all patients can wait for result before starting treatment if result will be more than eight hours post-ingestion AND dose taken >150 mg/kg (or 12 g total), start N- acetyl cysteine while waiting for result treat patient with IV N-acetyl cysteine if levels above the treatment line are relevant to patient s risk group if below treatment line and already started N-acetyl cysteine, stop the infusion 8-15 hours (all patients) take blood for paracetamol level, INR, U&E and LFT if >150 mg/kg (or 12 g total) taken, start N-acetyl cysteine while waiting for the paracetamol level if paracetamol level is below the treatment line for high risk group and creatinine, INR and alanine transferase are all normal, the N-acetyl cysteine can be discontinued. If not, admit for full course of treatment with N-acetyl cysteine hours (all patients) take blood for paracetamol level, INR, U&E, bicarbonate and LFT start N-acetyl cysteine infusion unless you are absolutely certain that the amount taken does not exceed 150 mg/kg (or 12 g total) the nomogram for prediction of liver damage is less accurate after 15 hours, so admit patient for a full course of N-acetyl cysteine > 24 hours (all patients) take blood for INR, U&E, bicarbonate/venous blood gases and LFTs paracetamol level is irrelevant at this stage as it will all have been excreted or metabolised if any of the blood tests are abnormal, the case should be discussed with the local liver unit treatment with N-acetyl cysteine may be suggested by the liver unit

5 Staggered overdose or time unavailable take blood for INR, U&E and LFTs paracetamol level is not relevant, but often taken to confirm ingestion if more than 150 mg/kg taken, or suspected, commence N-acetyl cysteine infusion and admit for full course of treatment if all blood tests are normal 24 hours after last ingestion then significant toxicity is unlikely and infusion can be stopped King s College transplantation criteria 1. Arterial ph < Lactate >3.0 mmol/l (despite fluid resuscitation) 3. Creatinine >300 µmol/l 4. INR >6.5 or PT >100 seconds 5. Grade 3 or 4 hepatic encephalopathy Psychiatric involvement Current NICE guidelines suggest that all children and most adults who have self-harmed should be admitted for a period, followed by a psychosocial assessment by a mental health professional.

PARACETAMOL POISONING

PARACETAMOL POISONING Background Resuscitation Risk Assessment Supportive Care Decontamination Paracetamol Levels Nomogram Antidote N-acetylcysteine (NAC) Table NAC infusion guide Timing of Investigations Risk factors for Paracetamol

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Paracetamol...10.00 mg for 1 ml of solution for infusion

SUMMARY OF PRODUCT CHARACTERISTICS. Paracetamol...10.00 mg for 1 ml of solution for infusion SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol...10.00 mg for 1 ml of

More information

PARACETAMOL REXIDOL. 600 mg Tablet. Analgesic-Antipyretic. Paracetamol 600 mg

PARACETAMOL REXIDOL. 600 mg Tablet. Analgesic-Antipyretic. Paracetamol 600 mg (Insert Text) UL Consumer Health PARACETAMOL REXIDOL 600 mg Tablet Analgesic-Antipyretic FORMULATION Each tablet contains: Paracetamol 600 mg PRODUCT DESCRIPTION Rexidol is a round, yellow, flat, bevel-edged

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 10 mg/ml solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution for infusion contains 10 mg paracetamol.

More information

Perfalgan 10 mg/ml, solution for infusion

Perfalgan 10 mg/ml, solution for infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Perfalgan 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need

More information

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May PERFALGAN 10 mg/ml

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May PERFALGAN 10 mg/ml The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2012. PERFALGAN 10 mg/ml Prescribing Information 1. NAME OF THE MEDICINAL PRODUCT PERFALGAN

More information

The early symptoms of acute salicylism are the triad of gastrointestinal distress, tinnitus or altered hearing, and hyperventilation.

The early symptoms of acute salicylism are the triad of gastrointestinal distress, tinnitus or altered hearing, and hyperventilation. POISONING SALICYLATES (ASPIRIN) Management Guidelines Emergency Department Princess Margaret Hospital for Children Perth, Western Australia Last reviewed: January 2007 Page 1 of 5 Dr Gary Geelhoed Dr Frank

More information

Doxylamine succinate belongs to the ethanolamine class of antihistamines with sedative properties.

Doxylamine succinate belongs to the ethanolamine class of antihistamines with sedative properties. Data Sheet MERSYNDOL Tablet Paracetamol 450mg per tablet Codeine Phosphate 9.75mg per tablet Doxylamine Succinate 5mg per tablet MERSYNDOL FORTE Tablet Paracetamol 450mg per tablet Codeine Phosphate 30mg

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

PRODUCT INFORMATION PANAMAX

PRODUCT INFORMATION PANAMAX NAME OF THE MEDICINE Non-proprietary Name Paracetamol PRODUCT INFORMATION PANAMAX DESCRIPTION Each tablet contains paracetamol 500 mg. The inactive ingredients are: maize starch, purified talc, pregelatinised

More information

Elements for a public summary. VI.2.1 Overview of disease epidemiology. VI.2.2 Summary of treatment benefits

Elements for a public summary. VI.2.1 Overview of disease epidemiology. VI.2.2 Summary of treatment benefits VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Pain is one of the most common reasons for a patient to seek medical attention. Moderate or severe intensity pain can be acute

More information

HCSP TRAINING MANUAL

HCSP TRAINING MANUAL HCSP TRAINING MANUAL SECTION II: THE LIVER Alan Franciscus, Editor-in-Chief The information in this guide is designed to help you understand and manage HCV and is not intended as medical advice. All persons

More information

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC) Indication: NICE TA181 First line treatment option in advanced or metastatic non-squamous NSCLC (histology confirmed as adenocarcinoma or large cell carcinoma) Performance status 0-1 Regimen details: Pemetrexed

More information

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour. Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol Hospira 10 mg/ml Solution for Infusion Paracetamol For children and adults from 33 kg up (approximately 11 years) Read all of this leaflet carefully

More information

Holy Family Hospital Dr Sarah Daniels April 2009

Holy Family Hospital Dr Sarah Daniels April 2009 Holy Family Hospital Dr Sarah Daniels April 2009 1 Topics to be covered Pharmacokinetics Pharmacodynamics Drug use in special groups Infants Children Elderly Pregnancy Polypharmacy 2 Pharmacokinetics Pharmacokinetics:

More information

Dangers of Tylenol (Acetaminophen) Dan Murphy, DC

Dangers of Tylenol (Acetaminophen) Dan Murphy, DC Dangers of Tylenol (Acetaminophen) 1 Dan Murphy, DC In 1994, researchers from Johns Hopkins Medical School published in the New England Journal of Medicine an article noting (1): Risk of Kidney Failure

More information

Core RMP agreed by the PhVWP in April 2012

Core RMP agreed by the PhVWP in April 2012 Paracetamol, solution for infusion (MRP Perfalgan (FR) and generic products) and risk of accidental overdosing of neonates and infants (due to medication errors following confusion between mg and ml) Core

More information

Maintenance of abstinence in alcohol dependence

Maintenance of abstinence in alcohol dependence Shared Care Guideline for Prescription and monitoring of Acamprosate Calcium Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist, Alcohol Services Dr Donnelly

More information

Toxicology Case Studies Acetaminophen and Liver Function

Toxicology Case Studies Acetaminophen and Liver Function Toxicology Case Studies Acetaminophen and Liver Function Alison Woodworth, PhD Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Nashville, TN Learning Objectives

More information

Teriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011).

Teriflunomide is the active metabolite of Leflunomide, a drug employed since 1994 for the treatment of rheumatoid arthritis (Baselt, 2011). Page 1 of 10 ANALYTE NAME AND STRUCTURE TERIFLUNOMIDE Teriflunomide TRADE NAME Aubagio CATEGORY Antimetabolite TEST CODE PURPOSE Therapeutic Drug Monitoring GENERAL RELEVANCY BACKGROUND sclerosis. The

More information

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,

More information

LEFLUNOMIDE (Adults)

LEFLUNOMIDE (Adults) Shared Care Guideline DRUG: Introduction: LEFLUNOMIDE (Adults) Indication: Disease modifying drug for rheumatoid arthritis and psoriatic arthritis Licensing Information: Disease modifying drug for active

More information

Nursing 113. Pharmacology Principles

Nursing 113. Pharmacology Principles Nursing 113 Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a. pharmacotherapeutics b. pharmacology c. pharmacodynamics

More information

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline

More information

Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC) Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC) Indication: In combination with docetaxel in locally advanced, metastatic or locally recurrent NSCLC of adenocarcinoma

More information

PANADOL OA 1000MG TABLETS PL 00071/0456 UKPAR TABLE OF CONTENTS

PANADOL OA 1000MG TABLETS PL 00071/0456 UKPAR TABLE OF CONTENTS PANADOL OA 1000MG TABLETS PL 00071/0456 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 13 Steps taken after authorisation summary Page 14 Summary

More information

Suspected 1080 (Fluoroacetate) Ingestion from Contaminated Infant and other Formulae

Suspected 1080 (Fluoroacetate) Ingestion from Contaminated Infant and other Formulae Suspected 1080 (Fluoroacetate) Ingestion from Contaminated Infant and other Formulae Guidance for general practitioners and urgent care medical specialists 8 March 2015 Infant & child feeding Key points

More information

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer )

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended

More information

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB Liver Function Tests Dr Stephen Butler Paediatric Advance Trainee TDHB Introduction Case presentation What is the liver? Overview of tests used to measure liver function RJ 10 month old European girl

More information

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide Medication for the Treatment of Alcohol Use Disorder Pocket Guide Medications are underused in the treatment of alcohol use disorder. According to the National Survey on Drug Use and Health, of the estimated

More information

KONAKION MM PAEDIATRIC

KONAKION MM PAEDIATRIC NAME OF THE MEDICINE KONAKION MM PAEDIATRIC Phytomenadione (vitamin K 1 ) CAS-84-80-0 O CH CH CH O CH CH = C CH CH CH CH CH 2 2 2 2 DESCRIPTION Konakion MM Paediatric contains as the active ingredient

More information

Safer Prescribing Workbook SECTION 5 CALCULATIONS AND INTRAVENOUS PRESCRIPTIONS

Safer Prescribing Workbook SECTION 5 CALCULATIONS AND INTRAVENOUS PRESCRIPTIONS Safer Prescribing Workbook SECTION 5 CALCULATIONS AND INTRAVENOUS PRESCRIPTIONS The objectives of this section are: To understand the rationale behind the rates, dilutions and compatibilities of intravenous

More information

PHOSPHATE-SANDOZ Tablets (High dose phosphate supplement)

PHOSPHATE-SANDOZ Tablets (High dose phosphate supplement) 1 PHOSPHATE-SANDOZ Tablets (High dose phosphate supplement) PHOSPHATE-SANDOZ PHOSPHATE-SANDOZ Tablets are a high dose phosphate supplement containing sodium phosphate monobasic. The CAS registry number

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

--------------------------------CONTRAINDICATIONS-------------------------------- Patients with previous anaphylactoid reaction to acetylcysteine (4)

--------------------------------CONTRAINDICATIONS-------------------------------- Patients with previous anaphylactoid reaction to acetylcysteine (4) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use safely and effectively. See full prescribing information for. ACETADOTE (acetylcysteine) Injection

More information

ANNEX 1 SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX 1 SUMMARY OF PRODUCT CHARACTERISTICS ANNEX 1 SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cimalgex 8 mg chewable tablets for dogs Cimalgex 30 mg chewable tablets for dogs Cimalgex 80 mg chewable tablets

More information

Review of Pharmacological Pain Management

Review of Pharmacological Pain Management Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization

More information

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP)

BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) BCCA Protocol Summary for Advanced Therapy for Relapsed Testicular Germ Cell Cancer Using PACLitaxel, Ifosfamide and CISplatin (TIP) Protocol Code Tumour Group Contact Physician UGUTIP Genitourinary Dr.

More information

Monitoring the condition of the mother during the first stage of labour

Monitoring the condition of the mother during the first stage of labour Before you begin this unit, please take the corresponding test at the end of the book to assess your knowledge of the subject matter. You should redo the test after you ve worked through the unit, to evaluate

More information

Chronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD) Chronic Kidney Disease (CKD) Most cats who live long enough develop some degree of kidney disease, and we can see it show up early even in younger cats. No one knows for sure what causes it; it is believed

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol)

MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol) MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol) 1. Hepatotoxicity: In Active TB Disease a. Background: 1. Among the 4 standard anti-tb drugs,

More information

Deramaxx : Smart Drug or Clever Marketing?

Deramaxx : Smart Drug or Clever Marketing? Deramaxx : Smart Drug or Clever Marketing? Edward Murray Jeff Levine s long-time, constant companion Rudy, a 9 year old Golden Retriever, died from internal bleeding after he had been administered a single

More information

Diabetic Emergencies. David Hill, D.O.

Diabetic Emergencies. David Hill, D.O. Diabetic Emergencies David Hill, D.O. Class Outline Diabetic emergency/glucometer training Identify the different signs of insulin shock Diabetic coma, and HHNK Participants will understand the treatment

More information

Prof. of Tropical Medicine Faculty of Medicine Alexandria University

Prof. of Tropical Medicine Faculty of Medicine Alexandria University prof. Dr. Ali El-Kady (MD) Prof. of Tropical Medicine Faculty of Medicine Alexandria University DRUGS THAT MAY CAUSE LIVER DYSFUNCTION DAMAGE The liver is the principal organ that is capable of converting

More information

See 17 for PATIENT COUNSELING INFORMATION. Revised: 3/2016 FULL PRESCRIBING INFORMATION: CONTENTS* WARNING: ADRENAL CRISIS IN THE SETTING OF SHOCK OR

See 17 for PATIENT COUNSELING INFORMATION. Revised: 3/2016 FULL PRESCRIBING INFORMATION: CONTENTS* WARNING: ADRENAL CRISIS IN THE SETTING OF SHOCK OR HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LYSODREN safely and effectively. See full prescribing information for LYSODREN. LYSODREN (mitotane)

More information

ANALYSIS OF POISON CONTROL CENTER DATA FOR ACETAMINOPHEN-CONTAINING PRODUCTS 1998-2000

ANALYSIS OF POISON CONTROL CENTER DATA FOR ACETAMINOPHEN-CONTAINING PRODUCTS 1998-2000 ANALYSIS OF POISON CONTROL CENTER DATA FOR ACETAMINOPHEN-CONTAINING PRODUCTS 1998-2000 Prepared by Julie A. Skare, PhD. Health Care Research Center The Procter & Gamble Company 8700 Mason-Montgomery Road

More information

Pain Management. Dr Kelly Reilly Dr Serena Martin

Pain Management. Dr Kelly Reilly Dr Serena Martin Pain Management Dr Kelly Reilly Dr Serena Martin Contents 1- Introduction 2- WHO ladder 3- Non-opioids 4- Opioids 5- Conversion 6- Conclusion Introduction Why do we give pain relief? Improve quality of

More information

Infliximab is used to treat psoriasis, psoriatic arthritis, and several other inflammatory conditions, including other inflammatory skin diseases.

Infliximab is used to treat psoriasis, psoriatic arthritis, and several other inflammatory conditions, including other inflammatory skin diseases. INFLIXIMAB What are the aims of this leaflet? This leaflet has been written to help you understand more about the medication infliximab. It tells you what it is, how it works, how it is used to treat skin

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental use by a child is a medical emergency

More information

Read all of this leaflet carefully because it contains important information for you.

Read all of this leaflet carefully because it contains important information for you. Package Leaflet: Information for the User Thioctacid 600 HR, Film-coated tablets For use in adults Active substance: Alpha-lipoic acid Read all of this leaflet carefully because it contains important information

More information

The Management of Acute Abdominal Pain in Children with Sickle Cell Disease

The Management of Acute Abdominal Pain in Children with Sickle Cell Disease The Management of Acute Abdominal Pain in Children with Sickle Cell Disease Version: 1 Date: 24 th March 2010 Authors: Responsible committee or Director: Review date: Target audience: Stakeholders/ committees

More information

Other commonly known names of vitamin A include Retinol, Retinal, Retinoic acid and Carotenoids.

Other commonly known names of vitamin A include Retinol, Retinal, Retinoic acid and Carotenoids. Medical Nutrition Therapy Nutrient: Vitamin A 1. What is the nutrient? Vitamin A is a fat-soluble group of retinoids including retinol, retinal, retinoic acid and retinyl esters. Vitamin A is involved

More information

Drugs for Alcohol Dependence: Clinical Guidance and Three Way Agreement

Drugs for Alcohol Dependence: Clinical Guidance and Three Way Agreement Drugs for Alcohol Dependence: Clinical Guidance and Three Way Agreement for County Durham In partnership with the GP, the client, and the County Durham Drug and Alcohol Service December 2015 Version 1.0

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

IBUPROFEN vs. IBUPROFEN vs. ACETAMINOPHEN. Which Painkiller is Better for Children with Viral Hepatitis?

IBUPROFEN vs. IBUPROFEN vs. ACETAMINOPHEN. Which Painkiller is Better for Children with Viral Hepatitis? IBUPROFEN vs. IBUPROFEN vs. ACETAMINOPHEN Which Painkiller is Better for Children with Viral Hepatitis? Adults and children with chronic viral hepatitis suffer the same fevers, colds and body aches as

More information

Calcium Folinate Ebewe Data Sheet

Calcium Folinate Ebewe Data Sheet NAME OF THE MEDICINE Calcium folinate injection Composition Active: Calcium folinate (equivalent to 10 mg folinic acid per ml) Inactive: Sodium chloride (7.7mg/mL), qs Water for Injections. Preservative

More information

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:. The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal

More information

Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject

Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: Guideline for administering Ferinject Guideline Number: 18 Guideline Version: a Developed By: Louise Kelly CNM 1 Renal Day Care

More information

Contact: Rebecca Wong (415) Questions and Answers Regarding Vidaza (azacitidine for injectable suspension) and Demethylating Agents

Contact: Rebecca Wong (415) Questions and Answers Regarding Vidaza (azacitidine for injectable suspension) and Demethylating Agents Contact: Rebecca Wong (415) 278-3319 Questions and Answers Regarding Vidaza (azacitidine for injectable suspension) and Demethylating Agents The recent approval of a third drug for the treatment of MDS

More information

Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction

Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction Hillsborough Community College - Ybor City Campus 1025C Laboratory Exercise 9: Testing Urine for the Presence of Drugs Introduction Drug testing beyond the health care and criminal justice systems has

More information

SAFE ANALGESIC USE IN CHRONIC KIDNEY DISEASE

SAFE ANALGESIC USE IN CHRONIC KIDNEY DISEASE 1 Doctor, I m in Pain! SAFE ANALGESIC USE IN CHRONIC KIDNEY DISEASE Ma Yuet Ting, BCACP Senior Pharmacist Khoo Teck Puat Hospital 2 Outline Common analgesics in CKD Paracetamol NSAIDs & Cox-2 Inhibitors

More information

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing! ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or

More information

Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition

Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition Copy 1 Location of copies Web based only The following guideline is for use by medical staff caring for the patient and members

More information

UNIVERSITY VETERINARY HOSPITAL & DIAGNOSTIC CENTER 952 East 900 South Salt Lake City, Utah 84105 (801) 596-9005

UNIVERSITY VETERINARY HOSPITAL & DIAGNOSTIC CENTER 952 East 900 South Salt Lake City, Utah 84105 (801) 596-9005 UNIVERSITY VETERINARY HOSPITAL & DIAGNOSTIC CENTER 952 East 900 South Salt Lake City, Utah 84105 (801) 596-9005 CHRONIC KIDNEY INSUFFICIENCY IN CATS By definition, kidney insufficiency or failure is the

More information

Glutathione and Oxidative Stress - Part I

Glutathione and Oxidative Stress - Part I Glutathione and Oxidative Stress - Part I By: James L. Holly, MD Oxidative Stress refers to effects from endogenous (produced in the body) toxins (free radicals) produced in the body by normal metabolism

More information

0.18% w/v Sodium Chloride and 4% w/v Glucose Intravenous Infusion BP Solution for infusion (Sodium chloride, Glucose)

0.18% w/v Sodium Chloride and 4% w/v Glucose Intravenous Infusion BP Solution for infusion (Sodium chloride, Glucose) PACKAGE LEAFLET: INFORMATION FOR THE USER B. Braun Melsungen AG 34209 Melsungen, Germany 0.18% w/v Sodium Chloride and 4% w/v Glucose Intravenous Infusion BP Solution for infusion (Sodium chloride, Glucose)

More information

Acid-Base Balance and the Anion Gap

Acid-Base Balance and the Anion Gap Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very

More information

Indicated for flu treatment for ages 2 weeks and older

Indicated for flu treatment for ages 2 weeks and older DOSAGE AND ADMINISTRATION IN ADULT AND PEDIATRIC PATIENTS Please see Important Safety Information on pages 6 8. Indicated for flu treatment for ages 2 weeks and older Available in 30-mg, 45-mg, and 75-mg

More information

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual

More information

4/29/2010. Osama Tabbara, R.Ph., BCNSP Consultant Pharmacist, TPN & IV Therapy Specialist

4/29/2010. Osama Tabbara, R.Ph., BCNSP Consultant Pharmacist, TPN & IV Therapy Specialist Safe Prescribing of IV Potassium in the ICU Osama Tabbara, R.Ph., BCNSP Consultant Pharmacist, TPN & IV Therapy Specialist Director, Pharmacy Services Administration KFMC otabbara@kfmc.med.sa Potentially

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 500 mg Effervescent Tablets Paracetamol Read all of this leaflet carefully because it contains important information for you. This medicine is available

More information

Clinical Guideline for the prophylaxis and treatment of fungal infections in Haematology patients

Clinical Guideline for the prophylaxis and treatment of fungal infections in Haematology patients Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Clinical Guideline for the prophylaxis and treatment

More information

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in March 2015. PERFALGAN 10 mg/ml

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in March 2015. PERFALGAN 10 mg/ml The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in March 2015. PERFALGAN 10 mg/ml Prescribing Information 1. NAME OF THE MEDICINAL PRODUCT PERFALGAN

More information

VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES

VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES VIVITROL (EXTENDED-RELEASE INJECTABLE NALTREXONE) MEDICAL PROTOCOL AND PROCEDURES INTRODUCTION This is the protocol and procedures to administer VIVITROL (extended-release naltrexone injection, or XR-NTX)

More information

PARACETAMOL 10MG/ML SOLUTION FOR INFUSION PL 20240/0004 UKPAR TABLE OF CONTENTS

PARACETAMOL 10MG/ML SOLUTION FOR INFUSION PL 20240/0004 UKPAR TABLE OF CONTENTS PARACETAMOL 10MG/ML SOLUTION FOR INFUSION PL 20240/0004 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 10 Steps taken after authorisation summary

More information

PREGNANCY AND THE LIVER

PREGNANCY AND THE LIVER Imtiaz Alam, M.D. Phone: [512] 719-4370 Mandy Mishra, CNS Fax: [512] 719-4371 Austin Hepatitis Center 12201, Renfert Way Suite 235 Austin, TX 78758 PREGNANCY AND THE LIVER How does pregnancy affect the

More information

What FLUCLOXACILLIN is used for and how it works

What FLUCLOXACILLIN is used for and how it works FLUCLOXACILLIN Flucloxacillin, as the sodium salt What is in this leaflet This leaflet answers some common questions about FLUCLOXACILLIN. It does not contain all the information available on this medicine.

More information

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE MEDICINAL PRODUCT DARROW 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients:

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE MEDICINAL PRODUCT DARROW 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients: SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT DARROW 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients: Sodium chloride - 4.0 g/l Sodium lactate - 5.9 g/l Potassium chloride

More information

This regimen has low emetogenic potential refer to local protocol None required routinely. Baseline results valid for 7 days. Results valid for 72 hrs

This regimen has low emetogenic potential refer to local protocol None required routinely. Baseline results valid for 7 days. Results valid for 72 hrs Regimen : Ipilimumab for Advanced Melanoma ICD10 code Codes pre-fixed with C43. Indication Regimen detail Ipilimumab is recommended as an option for treating advanced (unresectable or metastatic) melanoma

More information

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you

More information

EMEA PUBLIC STATEMENT ON LEFLUNOMIDE (ARAVA) - SEVERE AND SERIOUS HEPATIC REACTIONS -

EMEA PUBLIC STATEMENT ON LEFLUNOMIDE (ARAVA) - SEVERE AND SERIOUS HEPATIC REACTIONS - The European Agency for the Evaluation of Medicinal Products Post-authorisation evaluation of medicines for human use London, 12 March 2001 Doc. Ref: EMEA/H/5611/01/en EMEA PUBLIC STATEMENT ON LEFLUNOMIDE

More information

Paediatric fluids 13/06/05

Paediatric fluids 13/06/05 Dr Catharine Wilson Consultant Paediatric Anaesthetist Sheffield Children s Hospital. UK Paediatric fluids 13/06/05 Self assessment: Complete these questions before reading the tutorial. Discuss the answers

More information

Review Group: Mental Health Operational Medicines Management Group. Signature Signature Signature. Review Date: December 2014

Review Group: Mental Health Operational Medicines Management Group. Signature Signature Signature. Review Date: December 2014 Mental Health NHS Grampian Mental Health Service Staff Guidance For The Prescribing Of Vitamin Supplementation During In-Patient Admission (Mental Health) For Alcohol Withdrawal Co-ordinators: Consultant

More information

Nurses Self Paced Learning Module on Pain Management

Nurses Self Paced Learning Module on Pain Management Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa

More information

Naloxone Hydrochloride Injection PRODUCT INFORMATION

Naloxone Hydrochloride Injection PRODUCT INFORMATION Naloxone Hydrochloride Injection PRODUCT INFORMATION DESCRIPTION Naloxone hydrochloride is 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; C 19 H 21 NO 4.HCl. It is an off-white powder

More information

Psychology 472 Pharmacology of Psychoactive Drugs. Found in Tea. Found in Chocolate Has far less potency than caffeine

Psychology 472 Pharmacology of Psychoactive Drugs. Found in Tea. Found in Chocolate Has far less potency than caffeine Many Types of Xanthenes Stimulants Xanthenes and Caffeine Psychology 472 Pharmacology of Psychoactive Drugs Listen to the audio lecture while viewing these slides Xanthenes Theophylline (Tea) Theobromine

More information

BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY

BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY 1 BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY GUIDELINES ON ADMINISTRATION OF INTRAVENOUS IRON SUCROSE (VENOFER) AS A BOLUS DOSE IN THE RENAL OUTPATIENT SETTING Date Developed: August- October 2007 RENAL

More information

Risk stratification tool for children aged under 5 years with suspected sepsis

Risk stratification tool for children aged under 5 years with suspected sepsis Risk stratification tool for children aged under 5 years with suspected sepsis Category Age Behaviour No response to social cues Appears ill to a healthcare professional Does not wake, or if roused does

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

INTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline

INTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline Acknowledgements Background Well child with normal hydration Unwell children (+/- abnormal hydration Maintenance Deficit Ongoing losses (e.g. from drains) Which fluid? Monitoring Special Fluids Post-operative

More information

What Alcohol Does to the Body. Chapter 25 Lesson 2

What Alcohol Does to the Body. Chapter 25 Lesson 2 What Alcohol Does to the Body Chapter 25 Lesson 2 Short-Term Effects of Drinking The short-term term effects of alcohol on the body depend on several factors including: amount of alcohol consumed, gender,

More information

Department of Health. Rheynn Slaynt. Clinical Recommendations Committee

Department of Health. Rheynn Slaynt. Clinical Recommendations Committee Department of Health Rheynn Slaynt Clinical Recommendations Committee Recommendation 12/12 The Isle of Man Department of Health will provide as a Restricted Priority not a first-line treatment, Dabigatran

More information

Intraosseous Vascular Access and Lidocaine

Intraosseous Vascular Access and Lidocaine Intraosseous Vascular Access and Lidocaine Intraosseous (IO) needles provide access to the medullary cavity of a bone. It is a technique primarily used in emergency situations to administer fluid and medication

More information

Paracetamol apollo +9191 46 950 950. Paracetamol apollo +9191 46 950 950. Paracetamol

Paracetamol apollo +9191 46 950 950. Paracetamol apollo +9191 46 950 950. Paracetamol Paracetamol apollo +9191 46 950 950 Paracetamol apollo +9191 46 950 950 Paracetamol CAS Number : 103-90-2 Molecular Weight : 151.17 g/mol Molecular Formula : C8H9NO2 Systematic (IUPAC) : N-(4- hydroxyphenyl)ethanamide

More information

WHO Analgesic Ladder. + non opioid. Step 2. Mild to Moderate Pain Weak Opioid: Codeine, Dihydrocodeine, Tramadol

WHO Analgesic Ladder. + non opioid. Step 2. Mild to Moderate Pain Weak Opioid: Codeine, Dihydrocodeine, Tramadol Pain Management This guidance covers: WHO Analgesic Ladder Reducing dosing errors with opioids Opioid toxicity General Pain Management Acute General Pain Management Postoperative (excluding obstetrics)

More information

Data Sheet. Phytomenadione, 10 mg/1 ml and 2 mg/0.2 ml mixed micelle solution

Data Sheet. Phytomenadione, 10 mg/1 ml and 2 mg/0.2 ml mixed micelle solution Data Sheet Konakion MM Konakion MM paediatric Phytomenadione, 10 mg/1 ml and 2 mg/0.2 ml mixed micelle solution Procoagulant factor Composition Active ingredient Phytomenadione (synthetic vitamin K 1 ).

More information

RITUXIMAB (Rituxan) Rituximab 2007 Page 1 of 5

RITUXIMAB (Rituxan) Rituximab 2007 Page 1 of 5 RITUXIMAB (Rituxan) Rituximab is FDA approved for the treatment of low-grade or follicular CD20-positive, B-cell non-hodgkin's lymphoma (NHL); treatment of diffuse large B-cell CD20-positive NHL; treatment

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information